THIADIAZOLIDINEDIONES AS GSK-3 INHIBITORS

The present invention relates to new thiadiazolidinediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MEDINA PADILLA Miguel, MARTÍNEZ MONTERO Olga, PALOMO NICOLAU Francisco, HERRERO SANTOS Susana, PÉREZ DE LA CRUZ MORENO María Ángeles, DE CRISTOBAL BLANCO Javier, RODRÍGUEZ SALGUERO Beatriz, LÓPEZ OGALLA Javier, DOMÍNGUEZ CORREA Juan Manuel, FUERTES HUERTA Ana, SÁNCHEZ-QUESADA Jorge
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to new thiadiazolidinediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and autoimmune diseases and cardiovascular disorders. Additionally, there is provided a process for preparing such compounds, as well as pharmaceutical compositions comprising them.